8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001628280-21-012664
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cdxc-20210617.htm…